Oncology Institute, Inc.·4

May 21, 9:35 AM ET

Chernett Jorey 4

Research Summary

AI-generated summary

Updated

Oncology Institute (TOI) 10% Owner Jorey Chernett Buys 38,500 Shares

What Happened Jorey Chernett, a reported 10% owner of Oncology Institute, Inc. (TOI), purchased a total of 38,500 shares in two open-market transactions. On May 19, Chernett acquired 5,000 shares at $4.05 per share (about $20,250). On May 20, Chernett acquired 33,500 shares at a reported weighted-average price of $4.07 per share (about $136,345). These were purchases (buying stock), which are generally considered a more informative signal than routine sales.

Key Details

  • Transaction dates and amounts:
    • 2026-05-19: Purchase of 5,000 shares @ $4.05 — $20,250
    • 2026-05-20: Purchase of 33,500 shares @ $4.07 (weighted avg) — $136,345
  • Total shares bought: 38,500; total reported value: ~$156,595.
  • Shares owned after the transactions: not specified in the provided filing excerpt.
  • Filing timing: Report filed 2026-05-21 for transactions on 2026-05-19 and 2026-05-20; the filing appears timely (no late-filing indicator shown).
  • Footnote: The $4.07 price is a weighted-average rounded to the nearest cent. Purchases were made at prices ranging from $4.05 to $4.10; the insider offered to provide a breakdown of quantities at each price upon request.
  • Transaction code: P = Purchase (open-market/private purchase).

Context

  • As a 10% owner, Chernett is a large shareholder rather than necessarily a company executive; such purchases indicate the insider added to a significant stake but do not disclose motivation.
  • These were straightforward open-market buys (not option exercises, awards, or gifts), so there was no immediate sale or tax-withholding event reported.